ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions
Jump to:  View All • a b c d e f g h i j k [l] m n o p q r s t u v w x y z
  • Abstract Number: 2542
    La Positive, Ro60 Negative Subset of Primary Sjögren’s Syndrome Is a Reality
  • Abstract Number: 985
    Labial Salivary Gland Antibody-Secreting Cell Specificity and Characteristics in Sjögren’s Patients
  • Abstract Number: 739
    Lack of Association Between Esophageal Symptoms and Abnormal Findings in High-Resolution Manometry in a Mexican Mestizo Cohort with Systemic Sclerosis (SSc)
  • Abstract Number: 1637
    LACK of Association of ANTI CCP and Arthritis in SLE
  • Abstract Number: 1219
    Lack of Gene-Diuretic Interactions on Risk of Incident Gout: The Nurses’ Health Study and Health Professionals Follow-up Study
  • Abstract Number: 639
    Lack of Response Gene to Complement-32 Impairs Th17 Differentiation and Attenuates Lupus-like Chronic Graft Versus Host Disease
  • Abstract Number: 1700
    Laser Speckle Contrast Analysis in the Follow-up of Digital Ulcers in Systemic Sclerosis Patients
  • Abstract Number: 477
    Leflunomide Use Is Not Associated with an Increased Risk of Lung Disease in Rheumatoid Arthritis: A Meta-Analysis of Randomised Controlled Trials
  • Abstract Number: 1696
    Left Atrial Area Measurement Is Useful for Evaluating Left Ventricular Diastolic Dysfunction Coexisting with Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
  • Abstract Number: 200
    Leg Length Inequality and Hip Osteoarthritis
  • Abstract Number: 1025
    Leptin Production By Osteoarthritis Synovial Fibroblasts: Stimulation By Glucocorticoids and Mineralocorticoids through the Glucocorticoid Receptor and GILZ (Glucocorticoid-Induced Leucine Zipper) Protein 
  • Abstract Number: L10
    Lesinurad, a Novel Selective Uric Acid Reabsorption Inhibitor, in Two Phase III Clinical Trials: Combination Study of Lesinurad in Allopurinol Standard of Care Inadequate Responders (CLEAR 1 and 2)
  • Abstract Number: 420
    Less Is More: The Shorter Physical Function Measure Promis-PF10a Outperforms HAQ in an Ethnically Diverse, Urban Rheumatoid Arthritis Clinic Population
  • Abstract Number: 2363
    Leucine-Rich Alpha-2 Glycoprotein Is a Potential Disease Activity Marker Under IL-6 Suppression in Autoimmune Arthritis
  • Abstract Number: 1058
    Levels of Fatigue Are Dependent on Country of Residence in Rheumatoid Arthritis: An Analysis Among 3920 Patients from 17 Countries
  • Abstract Number: 387
    Levels of IgG Autoantibodies to Oxidation-Associated MDA Neo-Determinants Are a Biomarker for Systemic Inflammation and Disease Activity in SLE and RA
  • Abstract Number: 1346
    Leveraging Electronic Health Records to Improve Vaccination Rates for Patients with Rheumatoid Arthritis
  • Abstract Number: 2351
    Ligand of Glucocorticoid-Induced Tumor Necrosis Factor Receptor Enhances Th17 Cells Response in Collagen-Induced Arthritis Via P38 MAPK and STAT3 Pathway
  • Abstract Number: 2137
    Linear Extrapolation of Missing Radiographic Progression Scores Does Not Spuriously overestimate overall Radiographic Progression in Rheumatoid Arthritis
  • Abstract Number: 399
    Lipid Concentrations and Particle Sizes in Drug Naive Patients with Rheumatoid Arthritis
  • Abstract Number: 841
    Lipid Control and Cardiovascular Risk for Patients with Rheumatoid Arthritis Compared with Matched Non-Rheumatoid Arthritis Patients
  • Abstract Number: 636
    Liposomal-Glucocorticoids: A Novel Approach to the Therapy of SLE
  • Abstract Number: 92
    Long Noncoding RNA Nron Regulates the Activity of NFAT5 through Ubiquitin-Independent Proteasome Pathway in Rheumatoid Arthritis
  • Abstract Number: 293
    Long Term Functional Outcome and Quality of Life of Patients with Refractory Juvenile Idiopathic Arthritis Treated with Etanercept: Results of the Dutch Arthritis and Biologicals in Children Register
  • Abstract Number: 1559
    Long Term Improvements in Physical Function Are Associated with Improvements in Dactylitis, Enthesitis, Tender and Swollen Joint Counts, and Psoriasis Skin Involvement: Results from a Phase 3 Study of Ustekinumab in Psoriatic Arthritis Patients
  • Abstract Number: 1245
    Long Term Outcome of Infliximab in Severe and Refractory Systemic Sarcoidosis: Report of 16 Cases
  • Abstract Number: 913
    Long Term Outcomes of Patients with Moderate Creatine Kinase (CK) Elevation Seen in a Rheumatology Clinic
  • Abstract Number: 174
    Long Term Safety and Efficacy of Canakinumab Liquid Formulation in Acute Gouty Arthritis Patients: Results from a 36 Week Extension Study
  • Abstract Number: 479
    Long Term Safety of Intravenous Golimumab and Comparison with Subcutaneous Golimumab in Rheumatoid Arthritis:  Results through 2 Years
  • Abstract Number: L22
    Long-Term (104-Week) Safety and Efficacy of Monotherapy with Apremilast in DMARD-Naïve Patients with Psoriatic Arthritis: A Phase 3, Randomized, Controlled Trial and Open-Label Extension (PALACE 4)
  • Abstract Number: 1564
    Long-Term (104-Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial and Open-Label Extension
  • Abstract Number: 2517
    Long-Term Clinical, Structural, and Functional Consequences of Not Adopting Treatment in MTX Suboptimal Responders
  • Abstract Number: 2645
    Long-Term Efficacy and Safety of Pulse Cyclophosphamide for Neuropsychiatric Systemic Lupus Erythematosus: A Two-Centre Experience
  • Abstract Number: 1674
    Long-Term Efficacy of Rituximab in Systemic Sclerosis
  • Abstract Number: 957
    Long-Term Evaluation of NT-Probnp Levels in Ankylosing Spondylitis Patients Under TNF Blockers: A Marker of Persistent Disease Activity?
  • Abstract Number: 1782
    Long-Term Follow-up of Non-HBV Polyarteritis Nodosa and Microscopic Polyangiitis with Poor-Prognosis Factors
  • Abstract Number: 298
    Long-Term Impact of Juvenile Idiopathic Arthritis in the Greek adults’ Psychosocial Life
  • Abstract Number: 49
    Long-Term Oral Bisphosphonate Use for Osteoporosis Among Older Women – US and Canadian Perspective
  • Abstract Number: 2763
    Long-Term Outcome of Chronic Progressive Neurological Manifestations in Behcet’s Disease
  • Abstract Number: 1781
    Long-Term Outcomes Among Patients with Renal Disease Secondary to ANCA-Associated Vasculitis: Temporal Trends over 25 Years
  • Abstract Number: 813
    Long-Term Outcomes of Takayasu’s Arteritis Patients with Renal Artery Involvement
  • Abstract Number: 294
    Long-Term Pharmacokinetics of Body Surface Area-Adjusted Doses of Golimumab Following Repeated Subcutaneous Administrations in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis
  • Abstract Number: 1159
    Long-Term Quality of Life, Productivity Impairment, Disease Severity and Health Care Costs in Relation to Functional Impairment in Ankylosing Spondylitis Patients in the Czech Republic
  • Abstract Number: 273
    Long-Term Safety and Effectiveness of Adalimumab in Children with Moderately to Severely Active Polyarticular or Polyarticular-Course Juvenile Idiopathic Arthritis
  • Abstract Number: 545
    Long-Term Safety and Efficacy of Certolizumab Pegol over 96 Weeks in Patients with Psoriatic Arthritis with and without Prior Tumor Necrosis Factor Inhibitor Exposure
  • Abstract Number: 2505
    Long-Term Treatment with Tocilizumab (TCZ) Strongly Suppresses Joint Destruction in Biologic-naïve Patients with Rheumatoid Arthritis (RA) Regardless of Inflammation Status
  • Abstract Number: 262
    Longitudinal Assessment of Promis Pediatric Item Banks in Children with Chronic Musculoskeletal Pain
  • Abstract Number: 2931
    Longitudinal Examination with Salivary Gland Ultrasonography (SGUS) of Patients with Primary Sjogren’s Syndrome: A Single Center Experience
  • Abstract Number: 1724
    Loss of IRF5 Ameliorates Tissue Fibrosis in a Murine Model of Systemic Sclerosis
  • Abstract Number: 2907
    Loss of microRNA-146a Exacerbates Inflammatory Arthritis
  • Abstract Number: 2561
    Low Cardio-Respiratory Fitness Is Associated with Increased Arterial Stiffness in Patients with Ankylosing Spondylitis
  • Abstract Number: 1206
    Low Dose Colchicine Anti-Inflammatory Effects Are Transduced By AMP-Activated Protein Kinase (AMPK)
  • Abstract Number: 1407
    Low HAQ and Pain Predict Patient Perceived Remission in Rheumatoid Arthritis Patients Receiving MTX or Anti-TNF-Alpha Treatment
  • Abstract Number: 1427
    Low Prevalence of Sarcopenic Obesity in Rheumatoid Arthritis Patients with Moderate Clinical Activity
  • Abstract Number: L3
    Low Protein A20 Expression in Minor Salivary Glands Is Associated with Lymphoma Development in Primary Sjögren’s Syndrome
  • Abstract Number: 111
    Low Rates of Bone Mineral Density Testing in Medicare Beneficiaries with Breast Cancer Starting Aromatase Inhibitor Therapy
  • Abstract Number: 1410
    Low Rates of Cardiovascular Risk Factor Modification Among High-Risk Rheumatoid Arthritis Patients: Barrier to Cardiovascular Prevention Strategies?
  • Abstract Number: 2619
    Low Socioeconomic Status (SES) As Measured By Education Is (not) Associated with Worse Outcome in SLE: Data from the 1000 Canadian Faces of Lupus
  • Abstract Number: 1394
    Low Vitamin D Level Is Not Associated with Increased Risk of Cardiovascular Disease in Rheumatoid Arthritis Patients
  • Abstract Number: 220
    Lower Extremity Presarcopenia Is Associated with the Severity of Knee Pain
  • Abstract Number: 235
    Lower P1NP Serum Levels:  a Predictive Marker of Bone Loss after One-Year Follow-up in premenopausal SLE Patients
  • Abstract Number: 2118
    Lower Socioeconomic Status at Disease Onset Is Associated with Higher Health Care Costs in Patients with Systemic Lupus Erythematosus: A General Population-Based Cohort Study
  • Abstract Number: 734
    Lower Socioeconomic Status, Male Gender and Diffuse Scleroderma Are Associated with Worse Survival in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Cohort
  • Abstract Number: 878
    Luminex and Autoantigen Microarray Analysis of Sera from Patients with Diffuse Cutaneous Systemic Sclerosis Reveals Changes Associated with Imatinib Mesylate Treatment
  • Abstract Number: 2791
    Lung Cancer in SLE
  • Abstract Number: 2976
    Lung Ultrasound Screening for Interstitial Lung Disease in Rheumatoid Arthritis. Comparison with Usual Detection Algorithms in Clinical Practice
  • Abstract Number: 705
    Lupus Chest Pain in the Emergency Department:  a Common Diagnostic Dilemma
  • Abstract Number: 2989
    Lupus Impact Tracker Is Responsive to Changes in Disease Activity in Lupus
  • Abstract Number: 694
    Lupus Myocarditis: Clinical, Echocardiographic and Magnetic Resonance Characteristics
  • Abstract Number: 1311
    Lupus Nephritis in Mexican Children
  • Abstract Number: 1662
    Lupus Nephritis Patients Who Stopped Maintenance Immunosuppressive Therapy without Relapse
  • Abstract Number: 1655
    Lupus Nephritis: Clinicopathological Correlation in 126 Biopsies
  • Abstract Number: 690
    Lupus Patients Requiring First Corticosteroid Intervention Late in Disease Course – a Phenotypic Description
  • Abstract Number: 713
    Lupuspro Is Responsive to Changes in Disease Activity over Time
  • Abstract Number: 1
    Lymphocyte Proliferation to a Cross-Reactive Gut Commensal Candidate in Antiphospholipid Syndrome
Jump to:  View All • a b c d e f g h i j k [l] m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.